HUMNYSEHealthcare

Public company intelligence preview

HUMANA INC

97 insider trades surfaced from the last year. This page shows only aggregate signals, not the underlying transactions, people, filings, filters, or AI workspace.

Snapshot

A narrow read on a much deeper workspace.

The preview gives search visitors enough signal to understand coverage. It does not expose transaction records, person-level profiles, filters, comparisons, or analyst workflows.

Insider trades, last 12 months
97
9 filed in the last 30 days
Acquisition / disposition count
65/32
Buy / Sell
Unique insiders active in the last year
21
Current insider positions tracked
55
51 active, 4 exited

Insider compensation

Public aggregate: $8.2M average total compensation across covered insiders.

Governance movement

Public aggregate: 2 governance events in the last year.

Institutional ownership

Public aggregate: 854 holders from the latest quarter.

Restricted sales and governance

Public counts, not the investigation layer.

The full product opens the underlying filings, insider context, historical holdings, comparison tools, and AI analysis.

Restricted-sale filings, 1Y
0
Restricted-sale insiders, 1Y
0
Planned sale shares, 1Y
0
Planned sale value, 1Y
$0.00
Insiders covered
14
Latest year: 2025
Personnel changes, 1Y
2
Board appointments, 1Y
2
Board departures, 1Y
1

Market context

Basic quote context for the preview.

Price
$305.27
Market cap
$37.0B
Volume
16,211.851
EPS
$9.83
Revenue
$39.6B
Employees
67.1K

Company note

Context before the data.

Company Overview

Humana Inc. is a Healthcare company in the Healthcare Plans industry, with operations centered on Medicare Advantage, Medicare Part D, Medicaid/state-based contracts, TRICARE, and specialty insurance products, alongside CenterWell’s primary care, pharmacy, and home-based care services. The business is heavily weighted toward government-sponsored programs, with a large share of premiums and services revenue tied to federal contracts and Medicare-related reimbursement dynamics. Recent filings show strong revenue growth, but profitability has been affected by benefit-cost pressure, membership mix shifts, regulatory changes, and transformation-related charges. The company’s integrated, value-based care model and expanding CenterWell footprint make its operating results especially sensitive to utilization trends, CMS policy changes, and care management execution.

Executive Compensation Practices

Executive compensation at Humana is likely to be closely tied to metrics that matter most in Healthcare Plans: premium growth, medical cost control, benefit ratio performance, operating income, and cash generation. Because the company’s results are strongly influenced by Medicare Advantage, Part D, and state/government contract economics, incentive plans may also weight membership retention, star ratings, risk adjustment performance, and cost-of-care initiatives. CenterWell’s growth and profitability will likely factor into pay design as well, especially as management focuses on expanding primary care, pharmacy solutions, and home-based care while managing integration and margin pressure. In a business with frequent restructuring and transformation charges, boards often emphasize adjusted operating measures and strategic milestones so compensation does not overreact to one-time items such as impairments, litigation, or portfolio exits.

Insider Trading Considerations

Insider trading patterns for Humana may be influenced by the company’s sensitivity to CMS rulemaking, Medicare enrollment cycles, annual plan renewals, and quarterly claims-cost variability. Executives and directors may have more pronounced trading constraints or blackout windows around enrollment periods, star rating announcements, reimbursement updates, and earnings releases, since these events can materially move the stock. Because Humana depends heavily on government reimbursement and risk-adjustment dynamics, insiders may trade cautiously when visibility into utilization trends, reserve development, or regulatory changes is limited. Researchers should also watch for trades around major strategic actions, such as acquisitions, divestitures, restructuring charges, or policy-driven margin shifts, since these can create unusual insider activity in a Healthcare Plans company.

Unlock the full HUM insider intelligence workspace.

Move from public aggregate counts into transaction-level detail, people, filings, compensation history, ownership shifts, export tools, and AI-assisted analysis.

Individual insider trade details with transaction history
Insider compensation breakdown by position
Institutional holder analysis with quarterly comparisons
Insider holdings with temporal change tracking
Restricted sale filings with details
Governance data and personnel changes
10b5-1 trading plan analysis
AI-powered insights and conversational analysis
Board of directors profiles and governance data
Advanced filtering, sorting, and CSV export
7-day free trial included
Cancel anytime
Public preview vs full product
Trade-level transactions, filing links, codes, and footnotes
Available inside the authenticated dashboard, not on the public SEO preview.
Insider pay tables with role-level and year-over-year context
Available inside the authenticated dashboard, not on the public SEO preview.
Institutional holder shifts, concentration, and quarter comparisons
Available inside the authenticated dashboard, not on the public SEO preview.
Restricted-sale, governance, AI analysis, and export workflows
Available inside the authenticated dashboard, not on the public SEO preview.